Modal Capital

Modal Capital (also known as Modal Capital Partners) is a private equity and investment firm that specializes in the life sciences and biotechnology sectors. The firm is recognized for its strategic investments in high-growth healthcare companies, most notably its early-stage backing of Merrimack Pharmaceuticals. Founded by industry veterans including Nick Taylor, Modal Capital has historically operated as an event-driven investment entity, focusing on special situations and strategic growth opportunities within the global pharmaceutical and medical technology markets. The firm is primarily an investment vehicle rather than a drug development company and does not maintain an internal therapeutic pipeline.